Xiaoling Zhang

NIH Rank #4087
  • R01 Award PI

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12281035Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Anatomy & Cell Biology

NIH Funding · FY2026

Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#4,087
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Xiaoling Zhang as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG096052-02R01
    tRNA modifications regulating mitochondrial function and the mitochondrial proteome in AD/ADRD
    $750.8K
    award amount
  • 5R01AG080810-04R01
    The role of N6-methyladenosine modified RNA in Alzheimer's disease
    $736.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing Xiaoling Zhang as a PI.

FY2026 award administered by Boston University (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2024
    $1M Cumulative Linked Award Amount
  4. 2024
    Reached Top 50% by Award-Linked Rank
    Ranked #6441
  5. 2025
    $2M Cumulative Linked Award Amount
  6. 2025
    $5M Cumulative Linked Award Amount
  7. 2025
    Reached Top 25% by Award-Linked Rank
    Ranked #1115
  8. 2025
    Reached Top 10% by Award-Linked Rank
    Ranked #1115
  9. 2025
    R01 Award Record

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Xiaoling Zhang.